Navigation Links
ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
Date:11/16/2007

and Navelbine. Determining the safety of a single dose of ANX-530 was a secondary objective. In the first week, patients were dosed with either ANX-530 or Navelbine, and after a washout period, were dosed with the opposite drug during the second week of treatment. The FDA has indicated that this single clinical study, should it demonstrate pharmacokinetic equivalence between ANX-530 and Navelbine, would provide sufficient clinical data to support a Section 505(b)(2) NDA.

Pharmacokinetic equivalence was determined based on federal regulations and FDA guidance regarding bioequivalence studies. If the upper and lower bounds of the AUC ratio's and the Cmax ratio's 90% confidence interval ranged from 0.80 to 1.25, ANX-530 and Navelbine were considered to have equivalent pharmacokinetics. AUC is a measure of the total amount of the drug circulating in the body over time. Cmax is the maximum concentration of the drug measured in the blood at any given time. The results of a clinical study are actually estimates of what might be expected if the treatment were to be given to the entire population of interest. Confidence intervals indicate the precision of such an estimate. Pursuant to the study's protocol and statistical analysis plan, data from all 31 patients who received both study drugs were included in the analysis.

About ANX-530 (vinorelbine emulsion)

ANX-530 is a novel emulsion formulation of vinorelbine tartrate, a generic chemotherapy agent. ANX-530 is designed to reduce the incidence and severity of vein irritation from intravenous-delivery of vinorelbine tartrate. Vinorelbine tartrate works by disrupting microtubule formation and is a member of the vinca alkaloid class of antineoplastic agents. Vinorelbine is indicated as a single agent or in combination with cisplatin for treatment of advanced non-small cell lung cancer and has also shown activity in breast, ovarian, and other cancers.

About Section 505(b)(2)

Section 505(b)(2) of the
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
4. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
5. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
6. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
7. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
8. New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families
9. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
10. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 REPORT HIGHLIGHTS ... $3.7 billion in 2013. This market is expected to increase ... billion in 2019, with compound annual growth rate (CAGR) of ... This report provides: An in-depth analysis of ... market trends, with data from 2013, estimates for 2014, and ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... the addition of Jain PharmaBiotech,s new report ... Technologies, Markets and Companies" to their offering. ... nervous system (CNS) is a challenge in the ... directly into the CNS or administered systematically (e.g., ...
(Date:6/2/2015)... 2015 The North American ... concerned market with analysis and forecast of revenue. ... 2014, and is estimated to reach $632.5 million ... 2014 to 2019. Browse through the ... an analysis of industry trends and segments, with ...
Breaking Medicine Technology:Global Markets and Technologies for Medical Lasers 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3
... 16 The following is being,issued by Trust ... call to discuss a new report from the,American ... Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The report ... for children during a possible,pandemic flu outbreak and ...
... Oct. 16 Boston Scientific,Corporation (NYSE: ... the Company,s major,events and press announcements at ... Cardiovascular Therapeutics (TCT),scientific symposium, which runs from ... Boston Scientific will be announcing a ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7
(Date:6/2/2015)... Highly qualified dental care specialists inside the leading ... change in the dental tourism industry in Europe. As dentistry ... offers a full range of superior dental services in its ... , Partnered with a top medical tourism agency , ... and has earned a reputation as an influential provider for ...
(Date:6/2/2015)... 02, 2015 The Down Syndrome Association ... from the hit show Glee as the keynote speaker ... in Pleasant Prairie, WI. The event aims to raise ... Racine, Kenosha, and Walworth counties. , ... us for this important event," says Dawn Nuoffer, DSAW ...
(Date:6/2/2015)... Los Angeles (PRWEB) June 02, 2015 ... a letter of intent to partner and expand urgent ... is subject to approval by the University of California ... The planned transaction will allow UCLA Health to purchase ... centers in Beverly Hills, Calabasas, Newbury Park and Northridge ...
(Date:6/2/2015)... The Horizon Blue Cross Blue Shield ... Walking and Wellness Challenge, held this past weekend during ... another $3,000 for the Boys & Girls Club of ... 32,000 steps on her fitbit during her play at ... Club in Galloway Township. , When added to ...
(Date:6/2/2015)... 2015 Bitscape Infotech today announced it ... Worldwide Small and Midsized Cloud Solutions Award. The company ... partners for demonstrating excellence in innovation and implementation of ... comes as no surprise to us as we feel ... at worldwide level by Microsoft. We will continue to ...
Breaking Medicine News(10 mins):Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3
... Expected to Increase Annual Sales by 14.4 Million ... China Kangtai,Cactus Biotech Inc. (the "Company") (OTC Bulletin ... marketer of a,variety of cactus-based consumer products in ... products, Cactus Cattle Feed and Cactus Fish,Feed. It ...
... heart health, at least among men, a new study ... Gramling, M.D., D.Sc., found that men who believed they ... a three times lower incidence of death from heart ... the same conclusion among women. One possible explanation for ...
... how to reduce data security risks within their organization. , ... ... Kroll Fraud Solutions today launched " Handling Sensitive Patient Information ... healthcare professionals. , , ,From custodians and receptionists to nurses and ...
... Business Offers Premier Combat Lifesaver ... ... 14 In the summer of 2005, the,U.S. Army approached ... the requirements for the Combat Lifesaver program, and,at gaining their ...
... Experience 100 Million ... and Depend Upon, SAN FRANCISCO, July 14 BabyCenter, ... the world, announced,today the launch of a new social network. ... other and builds upon the,experience and expert voice parents have ...
... online NHS Health Guide for people,with diabetes has ... Choices, http://www.nhs.uk , The guide, http://www.nhs.uk/Pathways/diabetes/Pages/Landing.aspx, ... through to how to,live and self-manage the condition. ... out more guides from the 60 most common ...
Cached Medicine News:Health News:China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed 2Health News:Positive thinking is prescription for the heart 2Health News:Kroll Fraud Solutions Launches "Handling Sensitive Patient Information in the Healthcare Workplace: An eLearning Course for Safeguarding Patient Data" 2Health News:Creator of Recon Moutaineer's Tactical Combat Casualty Care Bag Praises Combat Lifesavers 2Health News:BabyCenter Launches Social Network for Largest Parenting Community Online 2Health News:BabyCenter Launches Social Network for Largest Parenting Community Online 3Health News:Diabetes Online Health Guide Released on NHS Choices 2
... with the CRW system for simplified functional ... cable drive mechanism to mimic the control ... of fluid leakage. The modular design of ... simplified removal during deep brain stimulator implantation. ...
... The OEV-203 Monitors are designed exclusively for ... use with all Olympus endoscopy systems. When ... equipment, the OEV-203 provides sharp, high-resolution images ... with the view - and details - ...
... lines of resolution with RGB, s-video and composite ... size selection and DC output availability. The on ... set up and operate the medical grade monitor. ... volume and aperture control. It also features a ...
... The Sony LMD-181MD medical grade flat panel is designed ... is perfect for endoscopy, surgery, radiology and ultrasound. It ... used on a overhead surgical arm. It allows for ... board and also has a built in VGA input. ...
Medicine Products: